Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001453687-21-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | 2021-10-01 | RNAC | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +13.8K | 194.3K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | A | A | 13,750 | $0.00 | 194,281 | D | — | — | (F2) Includes 2,753 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between March 1, 2021 and August 31, 2021. |